Pfizer, Inc.





Market Closed - Nyse 04:00:16 2023-12-01 pm EST Intraday chart for Pfizer, Inc. 5-day change 1st Jan Change
28.91 USD -5.12% -5.21% -43.58%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Health Up as Pfizer Slides -- Health Care Roundup DJ
S&P 500 hits highest 2023 close on rate cut hopes RE
Equity Markets Rise as Investors Weigh Fed Chair Remarks MT
Equity Markets Rise as Investors Weigh Fed Chair Remarks MT
US Equity Markets Close Higher Friday Following Powell's Comments on Rate Policy MT
Sector Update: Health Care Stocks Rise in Late Afternoon Trading MT
Wall St rallies as Powell cements peak rate bets RE
Sector Update: Health Care Stocks Rise in Afternoon Trading MT
Equity Markets Rise Intraday as Traders Weigh Fed Chair Remarks MT
Sector Update: Health Care MT
Powell's Restrictive Stand on Rate Hikes Pushes Equities Slightly Higher Friday Afternoon MT
Powell's Comments on Interest-Rate Hikes Leave Equities Modestly Higher Friday Afternoon MT
Wall St edges higher as Powell comments bolster peak-rate bets RE
Top Stories at Midday: Tesla's Cybertruck Hits the Road; Pfizer Pivots Danuglipron Development; Ulta Beats; Gaza Truce Ends; Powell Remains Restrictive MT
Pfizer Halts Development of Twice-Daily Weight Loss Drug MT
PFIZER INC : UBS sticks Neutral ZD
Global markets live: Meta, Tesla, BP Plc, Pfizer, General Motors...
Trending : Pfizer Obesity Drug Shows Mixed Study Results; Trial Discontinued DJ
PFIZER INC : JP Morgan remains Neutral ZD
Dpa-AFX Overview: COMPANIES from 01.12.2023 - 15:15 DP
Sector Update: Health Care Stocks Steady Pre-Bell Friday MT
Investors Await Fed Chief's Interest Rates Signal as Exchange-Traded Funds, Equity Futures Slide Pre-Bell Friday MT
Wall St set for lower open in run-up to Powell's remarks RE
Sector Update: Health Care MT
Will Powell deliver an early Christmas present?
Chart Pfizer, Inc.
More charts
Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows: - vaccines (52.4%); - drugs for the treatment of cancer (15.2%); - cardiovascular, metabolic and analgesic drugs (11.5%); - injectable, anti-infectives drugs and active pharmaceutical ingredients (9%); - drugs for inflammatory and immune diseases (5.5%); - drugs for rare diseases (4.4%); - other (2%). At the end of 2021, the group had more than 39 production sites worldwide. Net sales are distributed geographically as follows: the United States (36.6%), Europe (22.6%) and other (40.8%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
More Ratings
Mean consensus
Number of Analysts
Last Close Price
Average target price
Spread / Average Target
1st Jan change Capi.
-43.58% 163 B $
+59.64% 525 B $
+48.98% 454 B $
-10.34% 381 B $
-11.26% 253 B $
-17.52% 221 B $
+2.14% 202 B $
-9.09% 200 B $
+3.74% 146 B $
-4.52% 117 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock Pfizer, Inc. - Nyse
  4. News Pfizer, Inc.
  5. Pfizer's Abrysvo Recommended by CDC for Pregnant Individuals to Protect Infants from RSV
As early as today, start finding the best investment opportunities!
Optimize my profits